# FDA Inspection 1273753 - SPS Pharma Services - March 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/sps-pharma-services/97b09431-b33c-4a30-9288-6a183eaebb6b
Source feed: FDA_Inspections

> FDA Inspection 1273753 for SPS Pharma Services on March 13, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273753
- Company Name: SPS Pharma Services
- Inspection Date: 2024-03-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1120458 - 2020-02-07](https://www.keypedia.com/records/fda_inspections/sps-pharma-services/e110ff75-2f98-416d-9a76-c72862e851b4)
- [FDA Inspection 1054398 - 2018-05-29](https://www.keypedia.com/records/fda_inspections/sps-pharma-services/1a757d09-f516-47d1-82bf-783b96eb59ee)

Company: https://www.keypedia.com/companies/sps-pharma-services/9db6a4c9-c00a-428e-8b15-f3f60f0b851e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c